Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of cell killing (GO:0031342) | 7.02401116 |
2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 7.02401116 |
3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.55516871 |
4 | alanine transport (GO:0032328) | 6.17418192 |
5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.16170706 |
6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.84361565 |
7 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.60765181 |
8 | thymic T cell selection (GO:0045061) | 5.14840300 |
9 | negative regulation of astrocyte differentiation (GO:0048712) | 5.12606911 |
10 | positive T cell selection (GO:0043368) | 5.03660493 |
11 | positive regulation of cellular amide metabolic process (GO:0034250) | 5.02589802 |
12 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.97332073 |
13 | L-serine transport (GO:0015825) | 4.95987310 |
14 | positive thymic T cell selection (GO:0045059) | 4.93410356 |
15 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.92669274 |
16 | low-density lipoprotein particle remodeling (GO:0034374) | 4.90781461 |
17 | cellular response to interleukin-15 (GO:0071350) | 4.90109921 |
18 | T cell selection (GO:0045058) | 4.86949271 |
19 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 4.82417945 |
20 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.81968062 |
21 | C4-dicarboxylate transport (GO:0015740) | 4.76538803 |
22 | response to interleukin-15 (GO:0070672) | 4.76087052 |
23 | regulation of gamma-delta T cell activation (GO:0046643) | 4.72247221 |
24 | cellular response to cholesterol (GO:0071397) | 4.67058373 |
25 | leukocyte aggregation (GO:0070486) | 4.51060386 |
26 | tolerance induction (GO:0002507) | 4.50418618 |
27 | serine transport (GO:0032329) | 4.50171575 |
28 | regulation of T cell tolerance induction (GO:0002664) | 4.41079075 |
29 | * T cell migration (GO:0072678) | 4.35164723 |
30 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.25920567 |
31 | sodium ion export (GO:0071436) | 4.25130044 |
32 | cellular potassium ion homeostasis (GO:0030007) | 4.19107873 |
33 | L-amino acid import (GO:0043092) | 4.18706297 |
34 | amino acid import (GO:0043090) | 4.10632215 |
35 | activated T cell proliferation (GO:0050798) | 4.07963727 |
36 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 4.05671542 |
37 | regulation of beta-amyloid formation (GO:1902003) | 4.04268039 |
38 | cellular response to sterol (GO:0036315) | 3.96418426 |
39 | alpha-linolenic acid metabolic process (GO:0036109) | 3.90827530 |
40 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.88680006 |
41 | positive regulation of tolerance induction (GO:0002645) | 3.77197109 |
42 | interferon-gamma production (GO:0032609) | 3.76199757 |
43 | glial cell proliferation (GO:0014009) | 3.75406041 |
44 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.73568262 |
45 | reverse cholesterol transport (GO:0043691) | 3.73113679 |
46 | regulation of tolerance induction (GO:0002643) | 3.71100915 |
47 | regulation of regulatory T cell differentiation (GO:0045589) | 3.67758922 |
48 | negative regulation of T cell mediated immunity (GO:0002710) | 3.67323199 |
49 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.64263394 |
50 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.58049329 |
51 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.57888454 |
52 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.57888454 |
53 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 3.54747432 |
54 | chondroitin sulfate catabolic process (GO:0030207) | 3.54625016 |
55 | regulation of B cell differentiation (GO:0045577) | 3.54177928 |
56 | cell communication by electrical coupling (GO:0010644) | 3.53018522 |
57 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.51085452 |
58 | potassium ion import (GO:0010107) | 3.49909669 |
59 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.48373269 |
60 | T cell receptor signaling pathway (GO:0050852) | 3.47331861 |
61 | regulation of astrocyte differentiation (GO:0048710) | 3.46596144 |
62 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.45515084 |
63 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.45164273 |
64 | positive regulation of B cell differentiation (GO:0045579) | 3.39682793 |
65 | cellular response to type I interferon (GO:0071357) | 3.35536175 |
66 | type I interferon signaling pathway (GO:0060337) | 3.35536175 |
67 | negative regulation of response to reactive oxygen species (GO:1901032) | 3.34035730 |
68 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.31338911 |
69 | response to type I interferon (GO:0034340) | 3.31169378 |
70 | cholesterol catabolic process (GO:0006707) | 3.25145154 |
71 | sterol catabolic process (GO:0016127) | 3.25145154 |
72 | cGMP-mediated signaling (GO:0019934) | 3.24452330 |
73 | gamma-aminobutyric acid transport (GO:0015812) | 3.23691509 |
74 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.23577379 |
75 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.23135452 |
76 | signal complex assembly (GO:0007172) | 3.22191546 |
77 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.19545895 |
78 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 3.19328623 |
79 | regulation of phospholipid biosynthetic process (GO:0071071) | 3.18938137 |
80 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.18849703 |
81 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.18132821 |
82 | linoleic acid metabolic process (GO:0043651) | 3.17483247 |
83 | B cell receptor signaling pathway (GO:0050853) | 3.17029540 |
84 | detection of other organism (GO:0098543) | 3.16589335 |
85 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.15009321 |
86 | cellular sodium ion homeostasis (GO:0006883) | 3.13473707 |
87 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.13080642 |
88 | regulation of cholesterol esterification (GO:0010872) | 3.12278690 |
89 | detection of bacterium (GO:0016045) | 3.07990714 |
90 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.07111442 |
91 | positive regulation of granulocyte differentiation (GO:0030854) | 3.06766938 |
92 | positive regulation of interleukin-4 production (GO:0032753) | 3.06321073 |
93 | dermatan sulfate metabolic process (GO:0030205) | 3.05076945 |
94 | positive regulation of humoral immune response (GO:0002922) | 3.04193475 |
95 | response to cholesterol (GO:0070723) | 3.03075129 |
96 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 3.00890870 |
97 | modulation by symbiont of host defense response (GO:0052031) | 3.00712462 |
98 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.00712462 |
99 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.00712462 |
100 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.00712462 |
101 | modulation by symbiont of host immune response (GO:0052553) | 3.00712462 |
102 | positive regulation by symbiont of host defense response (GO:0052509) | 3.00712462 |
103 | plasma lipoprotein particle assembly (GO:0034377) | 2.99037694 |
104 | positive regulation of interleukin-2 production (GO:0032743) | 2.98156249 |
105 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.96929098 |
106 | mast cell activation (GO:0045576) | 2.96588104 |
107 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.96517490 |
108 | dermatan sulfate biosynthetic process (GO:0030208) | 2.96362635 |
109 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.93765854 |
110 | response to auditory stimulus (GO:0010996) | 2.91765128 |
111 | plasma lipoprotein particle remodeling (GO:0034369) | 2.91569458 |
112 | protein-lipid complex remodeling (GO:0034368) | 2.91569458 |
113 | macromolecular complex remodeling (GO:0034367) | 2.91569458 |
114 | locomotory exploration behavior (GO:0035641) | 2.91276441 |
115 | plasma lipoprotein particle organization (GO:0071827) | 2.90019982 |
116 | cellular modified amino acid catabolic process (GO:0042219) | 2.88071149 |
117 | cellular extravasation (GO:0045123) | 2.87942191 |
118 | negative regulation of phagocytosis (GO:0050765) | 2.86193928 |
119 | regulation of alpha-beta T cell activation (GO:0046634) | 2.84380219 |
120 | regulation of cell killing (GO:0031341) | 2.84335416 |
121 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.83479683 |
122 | negative regulation of innate immune response (GO:0045824) | 2.81998172 |
123 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.81530202 |
124 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.81159092 |
125 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.80738721 |
126 | adenine nucleotide transport (GO:0051503) | 2.80283707 |
127 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.78540899 |
128 | negative regulation of glial cell differentiation (GO:0045686) | 2.78053699 |
129 | response to sterol (GO:0036314) | 2.75323415 |
130 | myeloid dendritic cell differentiation (GO:0043011) | 2.75252389 |
131 | T cell homeostasis (GO:0043029) | 2.75030088 |
132 | regulation of cellular amide metabolic process (GO:0034248) | 2.74999808 |
133 | positive regulation of cell killing (GO:0031343) | 2.73828829 |
134 | * lymphocyte migration (GO:0072676) | 2.73652182 |
135 | doxorubicin metabolic process (GO:0044598) | 2.73052326 |
136 | daunorubicin metabolic process (GO:0044597) | 2.73052326 |
137 | polyketide metabolic process (GO:0030638) | 2.73052326 |
138 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.72951765 |
139 | negative regulation of interleukin-12 production (GO:0032695) | 2.72714747 |
140 | endothelium development (GO:0003158) | 2.72493886 |
141 | protein-lipid complex subunit organization (GO:0071825) | 2.71442537 |
142 | regulation of interleukin-4 production (GO:0032673) | 2.70744357 |
143 | T cell costimulation (GO:0031295) | 2.70289426 |
144 | atrial cardiac muscle cell action potential (GO:0086014) | 2.68449930 |
145 | dendritic cell chemotaxis (GO:0002407) | 2.68426160 |
146 | high-density lipoprotein particle remodeling (GO:0034375) | 2.68397190 |
147 | negative regulation of sodium ion transport (GO:0010766) | 2.67625924 |
148 | phospholipid efflux (GO:0033700) | 2.67023928 |
149 | proline transport (GO:0015824) | 2.66812952 |
150 | lymphocyte costimulation (GO:0031294) | 2.66468052 |
151 | protein-lipid complex assembly (GO:0065005) | 2.66041236 |
152 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.65646020 |
153 | NIK/NF-kappaB signaling (GO:0038061) | 2.65461404 |
154 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.64384992 |
155 | regulation of defense response to virus by virus (GO:0050690) | 2.63471658 |
156 | response to muramyl dipeptide (GO:0032495) | 2.63431449 |
157 | myeloid dendritic cell activation (GO:0001773) | 2.62927015 |
158 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.62548248 |
159 | ethanol oxidation (GO:0006069) | 2.61914271 |
160 | positive regulation of alpha-beta T cell activation (GO:0046635) | 2.61771812 |
161 | macrophage activation involved in immune response (GO:0002281) | 2.61723911 |
162 | regulation of granulocyte differentiation (GO:0030852) | 2.60151103 |
163 | T cell differentiation (GO:0030217) | 2.59606598 |
164 | negative T cell selection (GO:0043383) | 2.58547792 |
165 | regulation of extracellular matrix disassembly (GO:0010715) | 2.58490135 |
166 | dendritic cell migration (GO:0036336) | 2.57658530 |
167 | purine nucleotide transport (GO:0015865) | 2.57554648 |
168 | fatty acid homeostasis (GO:0055089) | 2.57345585 |
169 | positive regulation of isotype switching (GO:0045830) | 2.57261269 |
170 | glycogen catabolic process (GO:0005980) | 2.56318850 |
171 | acidic amino acid transport (GO:0015800) | 2.56069485 |
172 | immunoglobulin mediated immune response (GO:0016064) | 2.55604377 |
173 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.55124093 |
174 | ovulation cycle (GO:0042698) | 2.53618366 |
175 | leukocyte cell-cell adhesion (GO:0007159) | 2.53406845 |
176 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.51237368 |
177 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.51237368 |
178 | negative regulation of tissue remodeling (GO:0034104) | 2.50273167 |
179 | negative regulation of smoothened signaling pathway (GO:0045879) | 2.47746372 |
180 | negative thymic T cell selection (GO:0045060) | 2.47036104 |
181 | phagocytosis, recognition (GO:0006910) | 2.45794886 |
182 | regulation of extracellular matrix organization (GO:1903053) | 2.45780754 |
183 | regulation of apoptotic cell clearance (GO:2000425) | 2.44368942 |
184 | negative regulation of protein oligomerization (GO:0032460) | 2.43148410 |
185 | glutamate metabolic process (GO:0006536) | 2.42985971 |
186 | regulation of cholesterol metabolic process (GO:0090181) | 2.42221283 |
187 | regulation of cholesterol homeostasis (GO:2000188) | 2.40859975 |
188 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.40540946 |
189 | lens fiber cell development (GO:0070307) | 2.38251957 |
190 | glucan catabolic process (GO:0009251) | 2.36560479 |
191 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.34881777 |
192 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.34433345 |
193 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.34141450 |
194 | potassium ion homeostasis (GO:0055075) | 2.33873617 |
195 | axon ensheathment in central nervous system (GO:0032291) | 2.32748781 |
196 | central nervous system myelination (GO:0022010) | 2.32748781 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.53876601 |
2 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.30326532 |
3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.04448256 |
4 | * MYB_26560356_Chip-Seq_TH2_Human | 2.82389247 |
5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.79864570 |
6 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.76902284 |
7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.75805509 |
8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.66115465 |
9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.64253803 |
10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.53128421 |
11 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.48512914 |
12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.46871065 |
13 | * MAF_26560356_Chip-Seq_TH1_Human | 2.38623577 |
14 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.35240581 |
15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.27310928 |
16 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.20098885 |
17 | UTX_26944678_Chip-Seq_JUKART_Human | 2.20072290 |
18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.19605949 |
19 | * MYB_26560356_Chip-Seq_TH1_Human | 2.17325030 |
20 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.12947417 |
21 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.10991668 |
22 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.08105482 |
23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06225555 |
24 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.01248135 |
25 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.96426686 |
26 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.95717848 |
27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.95464049 |
28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.94821699 |
29 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.94621817 |
30 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.92728670 |
31 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.84689306 |
32 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.81359971 |
33 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.78180096 |
34 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.77796608 |
35 | * MAF_26560356_Chip-Seq_TH2_Human | 1.76809712 |
36 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.74742131 |
37 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.74172795 |
38 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.74172795 |
39 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.70506421 |
40 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.68952202 |
41 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.68562051 |
42 | SPI1_23127762_ChIP-Seq_K562_Human | 1.66674751 |
43 | RXR_22108803_ChIP-Seq_LS180_Human | 1.63471218 |
44 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.62812810 |
45 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.57303187 |
46 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.55492934 |
47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.53636565 |
48 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53527060 |
49 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.52934596 |
50 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.51557450 |
51 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.51546653 |
52 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.51256008 |
53 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.51201938 |
54 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50787412 |
55 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.50506051 |
56 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.49560485 |
57 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.49314897 |
58 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.48832369 |
59 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.46311094 |
60 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.45923055 |
61 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.43947982 |
62 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.42502756 |
63 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.41228426 |
64 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.41222226 |
65 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.40520630 |
66 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.39713189 |
67 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.38176681 |
68 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35319723 |
69 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.29884525 |
70 | MYC_22102868_ChIP-Seq_BL_Human | 1.29079376 |
71 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.27980250 |
72 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.27601476 |
73 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.27176086 |
74 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.27017508 |
75 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.25611946 |
76 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.25493515 |
77 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.24196254 |
78 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23564203 |
79 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.21322337 |
80 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.20522895 |
81 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.20287606 |
82 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.19635174 |
83 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.19537431 |
84 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19430767 |
85 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19046164 |
86 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.17941471 |
87 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.16346041 |
88 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.14758167 |
89 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.12191809 |
90 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.10839546 |
91 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.09334105 |
92 | GATA1_19941826_ChIP-Seq_K562_Human | 1.09265163 |
93 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.08639738 |
94 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.08408333 |
95 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07549056 |
96 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.06547844 |
97 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.06372988 |
98 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06203411 |
99 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.05794643 |
100 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05009185 |
101 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04799036 |
102 | TP53_16413492_ChIP-PET_HCT116_Human | 1.04310913 |
103 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.03346151 |
104 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.02475365 |
105 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.01664840 |
106 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.01307378 |
107 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.00812312 |
108 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00186338 |
109 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.98917372 |
110 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.97301521 |
111 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.97137133 |
112 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.96986461 |
113 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.96668383 |
114 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.96668383 |
115 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.96177764 |
116 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.95967371 |
117 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95071047 |
118 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94882658 |
119 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.94402013 |
120 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.93902317 |
121 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.93161521 |
122 | AR_25329375_ChIP-Seq_VCAP_Human | 0.93057376 |
123 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.92777302 |
124 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.92591411 |
125 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.91687736 |
126 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.90541161 |
127 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.89677348 |
128 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.88595557 |
129 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87993567 |
130 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.86781832 |
131 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.86204094 |
132 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.85583732 |
133 | AR_19668381_ChIP-Seq_PC3_Human | 0.85315599 |
134 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.84978954 |
135 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.83573726 |
136 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.83500832 |
137 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.83500832 |
138 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.83305032 |
139 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.82990589 |
140 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82659286 |
141 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82526390 |
142 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.82361688 |
143 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.82234893 |
144 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.81905411 |
145 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80655303 |
146 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.80586749 |
147 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.80444308 |
148 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.80309336 |
149 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.80097336 |
150 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.78876863 |
151 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.78385621 |
152 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.78180500 |
153 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77896026 |
154 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76880616 |
155 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.75789168 |
156 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.75511814 |
157 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.75091986 |
158 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.74932446 |
159 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.70442549 |
160 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.69747394 |
161 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.69378026 |
162 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.67741410 |
163 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.67521387 |
164 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.67418250 |
165 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.67013967 |
166 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.67013967 |
167 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.67013967 |
168 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.66798052 |
169 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.66352494 |
170 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.65746613 |
171 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.65165912 |
172 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.64957328 |
173 | GATA3_26560356_Chip-Seq_TH1_Human | 0.63289818 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002254_reproductive_system_inflammat | 4.58769010 |
2 | MP0003690_abnormal_glial_cell | 3.91582880 |
3 | MP0009840_abnormal_foam_cell | 3.48251691 |
4 | MP0003436_decreased_susceptibility_to | 3.37737549 |
5 | MP0003329_amyloid_beta_deposits | 3.37300899 |
6 | MP0003279_aneurysm | 3.24267875 |
7 | MP0001835_abnormal_antigen_presentation | 3.23303101 |
8 | MP0005000_abnormal_immune_tolerance | 2.85453830 |
9 | MP0009384_cardiac_valve_regurgitation | 2.56098244 |
10 | MP0002723_abnormal_immune_serum | 2.51599658 |
11 | * MP0002420_abnormal_adaptive_immunity | 2.51588912 |
12 | MP0009785_altered_susceptibility_to | 2.51525489 |
13 | MP0005025_abnormal_response_to | 2.51304708 |
14 | MP0001853_heart_inflammation | 2.50953928 |
15 | MP0000604_amyloidosis | 2.47013399 |
16 | * MP0001819_abnormal_immune_cell | 2.46435273 |
17 | MP0003075_altered_response_to | 2.40096659 |
18 | MP0002452_abnormal_antigen_presenting | 2.35473465 |
19 | MP0005646_abnormal_pituitary_gland | 2.27982329 |
20 | MP0005167_abnormal_blood-brain_barrier | 2.21421414 |
21 | MP0006082_CNS_inflammation | 2.20268703 |
22 | MP0009333_abnormal_splenocyte_physiolog | 2.20061419 |
23 | MP0004858_abnormal_nervous_system | 2.15392723 |
24 | MP0002405_respiratory_system_inflammati | 2.13804350 |
25 | MP0004859_abnormal_synaptic_plasticity | 2.04114719 |
26 | MP0003300_gastrointestinal_ulcer | 2.00476534 |
27 | MP0009780_abnormal_chondrocyte_physiolo | 2.00087745 |
28 | * MP0002398_abnormal_bone_marrow | 1.97253034 |
29 | MP0003828_pulmonary_edema | 1.96840159 |
30 | * MP0000716_abnormal_immune_system | 1.94444661 |
31 | MP0002933_joint_inflammation | 1.89810957 |
32 | MP0004510_myositis | 1.89610849 |
33 | MP0010155_abnormal_intestine_physiology | 1.89185901 |
34 | MP0000703_abnormal_thymus_morphology | 1.87133208 |
35 | MP0010329_abnormal_lipoprotein_level | 1.86106279 |
36 | MP0001486_abnormal_startle_reflex | 1.85979093 |
37 | MP0001502_abnormal_circadian_rhythm | 1.82696777 |
38 | MP0005360_urolithiasis | 1.79417863 |
39 | MP0004885_abnormal_endolymph | 1.78988307 |
40 | MP0002148_abnormal_hypersensitivity_rea | 1.78739899 |
41 | MP0002166_altered_tumor_susceptibility | 1.77776234 |
42 | MP0001851_eye_inflammation | 1.76110359 |
43 | MP0005332_abnormal_amino_acid | 1.73563969 |
44 | MP0001533_abnormal_skeleton_physiology | 1.72953176 |
45 | MP0003633_abnormal_nervous_system | 1.71972422 |
46 | MP0004130_abnormal_muscle_cell | 1.70089388 |
47 | MP0002139_abnormal_hepatobiliary_system | 1.69066544 |
48 | MP0002909_abnormal_adrenal_gland | 1.62507457 |
49 | MP0003866_abnormal_defecation | 1.60957529 |
50 | MP0008569_lethality_at_weaning | 1.60812331 |
51 | MP0000689_abnormal_spleen_morphology | 1.60725172 |
52 | MP0004947_skin_inflammation | 1.60461631 |
53 | MP0002722_abnormal_immune_system | 1.60409545 |
54 | MP0010368_abnormal_lymphatic_system | 1.60334872 |
55 | MP0000685_abnormal_immune_system | 1.56552227 |
56 | MP0002638_abnormal_pupillary_reflex | 1.52456329 |
57 | MP0001879_abnormal_lymphatic_vessel | 1.52434543 |
58 | MP0004215_abnormal_myocardial_fiber | 1.49792930 |
59 | MP0001845_abnormal_inflammatory_respons | 1.48686719 |
60 | MP0005166_decreased_susceptibility_to | 1.47421683 |
61 | MP0005165_increased_susceptibility_to | 1.44624227 |
62 | * MP0002429_abnormal_blood_cell | 1.44410011 |
63 | MP0005365_abnormal_bile_salt | 1.43869393 |
64 | MP0003763_abnormal_thymus_physiology | 1.42397156 |
65 | MP0003635_abnormal_synaptic_transmissio | 1.38419997 |
66 | MP0002009_preneoplasia | 1.38082959 |
67 | MP0003634_abnormal_glial_cell | 1.33982624 |
68 | MP0005670_abnormal_white_adipose | 1.32805666 |
69 | MP0006054_spinal_hemorrhage | 1.32578524 |
70 | MP0005464_abnormal_platelet_physiology | 1.31568630 |
71 | MP0005377_hearing/vestibular/ear_phenot | 1.27761839 |
72 | MP0003878_abnormal_ear_physiology | 1.27761839 |
73 | MP0003631_nervous_system_phenotype | 1.25417248 |
74 | MP0009764_decreased_sensitivity_to | 1.22494376 |
75 | MP0005595_abnormal_vascular_smooth | 1.19973719 |
76 | MP0000343_altered_response_to | 1.16774113 |
77 | MP0003011_delayed_dark_adaptation | 1.16267295 |
78 | MP0001440_abnormal_grooming_behavior | 1.15949620 |
79 | MP0003191_abnormal_cellular_cholesterol | 1.14335654 |
80 | MP0001873_stomach_inflammation | 1.12015336 |
81 | MP0008260_abnormal_autophagy | 1.11996205 |
82 | MP0002064_seizures | 1.11803399 |
83 | MP0005310_abnormal_salivary_gland | 1.10162968 |
84 | MP0002090_abnormal_vision | 1.09047475 |
85 | MP0002572_abnormal_emotion/affect_behav | 1.08507383 |
86 | MP0009745_abnormal_behavioral_response | 1.08283932 |
87 | MP0005387_immune_system_phenotype | 1.07787239 |
88 | MP0001790_abnormal_immune_system | 1.07787239 |
89 | MP0003448_altered_tumor_morphology | 1.07428987 |
90 | MP0003137_abnormal_impulse_conducting | 1.07228147 |
91 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.05027430 |
92 | MP0003183_abnormal_peptide_metabolism | 1.04302466 |
93 | MP0005647_abnormal_sex_gland | 1.03324818 |
94 | MP0002006_tumorigenesis | 1.03064574 |
95 | MP0004484_altered_response_of | 1.02557555 |
96 | MP0008469_abnormal_protein_level | 1.02290000 |
97 | MP0004381_abnormal_hair_follicle | 1.01718106 |
98 | MP0000858_altered_metastatic_potential | 1.01360773 |
99 | MP0002118_abnormal_lipid_homeostasis | 0.99923977 |
100 | MP0001958_emphysema | 0.99863737 |
101 | MP0002971_abnormal_brown_adipose | 0.99794980 |
102 | MP0004883_abnormal_blood_vessel | 0.98656524 |
103 | MP0002972_abnormal_cardiac_muscle | 0.96253874 |
104 | * MP0003091_abnormal_cell_migration | 0.96206153 |
105 | MP0002063_abnormal_learning/memory/cond | 0.96135940 |
106 | MP0000566_synostosis | 0.96030996 |
107 | MP0003632_abnormal_nervous_system | 0.93124189 |
108 | MP0005058_abnormal_lysosome_morphology | 0.93043499 |
109 | MP0001984_abnormal_olfaction | 0.92571743 |
110 | MP0001348_abnormal_lacrimal_gland | 0.92351871 |
111 | MP0002822_catalepsy | 0.91129932 |
112 | MP0003724_increased_susceptibility_to | 0.91054581 |
113 | MP0008875_abnormal_xenobiotic_pharmacok | 0.90168182 |
114 | MP0003303_peritoneal_inflammation | 0.89473855 |
115 | MP0009046_muscle_twitch | 0.88493857 |
116 | MP0000249_abnormal_blood_vessel | 0.86572318 |
117 | MP0005171_absent_coat_pigmentation | 0.85844502 |
118 | MP0002138_abnormal_hepatobiliary_system | 0.85812197 |
119 | MP0001501_abnormal_sleep_pattern | 0.84769731 |
120 | * MP0000767_abnormal_smooth_muscle | 0.84184903 |
121 | MP0000609_abnormal_liver_physiology | 0.83602496 |
122 | MP0005423_abnormal_somatic_nervous | 0.83451946 |
123 | MP0005671_abnormal_response_to | 0.83127993 |
124 | MP0002332_abnormal_exercise_endurance | 0.83070257 |
125 | MP0005164_abnormal_response_to | 0.80810926 |
126 | MP0000465_gastrointestinal_hemorrhage | 0.80021396 |
127 | MP0009763_increased_sensitivity_to | 0.79236495 |
128 | MP0003646_muscle_fatigue | 0.75931850 |
129 | MP0009278_abnormal_bone_marrow | 0.75855578 |
130 | MP0005666_abnormal_adipose_tissue | 0.75479288 |
131 | MP0002133_abnormal_respiratory_system | 0.75318113 |
132 | MP0005388_respiratory_system_phenotype | 0.75318113 |
133 | MP0004036_abnormal_muscle_relaxation | 0.75081186 |
134 | MP0001663_abnormal_digestive_system | 0.74042167 |
135 | MP0002998_abnormal_bone_remodeling | 0.73535820 |
136 | MP0005390_skeleton_phenotype | 0.73147307 |
137 | MP0002419_abnormal_innate_immunity | 0.72507688 |
138 | MP0005451_abnormal_body_composition | 0.72343460 |
139 | MP0002295_abnormal_pulmonary_circulatio | 0.71899847 |
140 | MP0002557_abnormal_social/conspecific_i | 0.71606206 |
141 | MP0009115_abnormal_fat_cell | 0.69883056 |
142 | MP0000920_abnormal_myelination | 0.69826105 |
143 | MP0001800_abnormal_humoral_immune | 0.69367950 |
144 | MP0000751_myopathy | 0.69155572 |
145 | * MP0002127_abnormal_cardiovascular_syste | 0.68912382 |
146 | MP0003045_fibrosis | 0.68819000 |
147 | MP0002733_abnormal_thermal_nociception | 0.68213864 |
148 | MP0003638_abnormal_response/metabolism_ | 0.68061737 |
149 | MP0002089_abnormal_postnatal_growth/wei | 0.67766862 |
150 | MP0006138_congestive_heart_failure | 0.67715064 |
151 | * MP0005385_cardiovascular_system_phenoty | 0.66713994 |
152 | * MP0001544_abnormal_cardiovascular_syste | 0.66713994 |
153 | MP0002928_abnormal_bile_duct | 0.65881069 |
154 | MP0002277_abnormal_respiratory_mucosa | 0.64189233 |
155 | MP0008004_abnormal_stomach_pH | 0.63849856 |
156 | MP0003795_abnormal_bone_structure | 0.52642536 |
157 | MP0004084_abnormal_cardiac_muscle | 0.50191386 |
158 | * MP0008874_decreased_physiological_sensi | 0.49477671 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Megalencephaly (HP:0001355) | 6.68454912 |
2 | Aplasia involving bones of the extremities (HP:0009825) | 5.74614572 |
3 | Aplasia involving bones of the upper limbs (HP:0009823) | 5.74614572 |
4 | Aplasia of the phalanges of the hand (HP:0009802) | 5.74614572 |
5 | Eczematoid dermatitis (HP:0000976) | 5.71102918 |
6 | Neurofibrillary tangles (HP:0002185) | 5.40357543 |
7 | Abnormality of T cell number (HP:0011839) | 5.24281819 |
8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.20049761 |
9 | Myositis (HP:0100614) | 4.96795337 |
10 | Stomatitis (HP:0010280) | 4.84204209 |
11 | Abnormality of binocular vision (HP:0011514) | 4.51768245 |
12 | Diplopia (HP:0000651) | 4.51768245 |
13 | Hemiplegia (HP:0002301) | 4.22964620 |
14 | Orchitis (HP:0100796) | 4.20034889 |
15 | Optic neuritis (HP:0100653) | 4.19288643 |
16 | Retrobulbar optic neuritis (HP:0100654) | 4.19288643 |
17 | Abnormality of secondary sexual hair (HP:0009888) | 4.12418103 |
18 | Abnormality of the axillary hair (HP:0100134) | 4.12418103 |
19 | Back pain (HP:0003418) | 4.04773083 |
20 | Cerebral inclusion bodies (HP:0100314) | 4.01005123 |
21 | Recurrent bacterial skin infections (HP:0005406) | 3.92169474 |
22 | Recurrent abscess formation (HP:0002722) | 3.84226263 |
23 | Abnormality of T cells (HP:0002843) | 3.78656653 |
24 | Recurrent bronchitis (HP:0002837) | 3.73663841 |
25 | Hyperlipoproteinemia (HP:0010980) | 3.70183548 |
26 | Recurrent fungal infections (HP:0002841) | 3.65393280 |
27 | Clumsiness (HP:0002312) | 3.62173587 |
28 | Abnormality of macrophages (HP:0004311) | 3.60073091 |
29 | Hypoplastic left heart (HP:0004383) | 3.56322013 |
30 | Pustule (HP:0200039) | 3.53368058 |
31 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.52121287 |
32 | Severe combined immunodeficiency (HP:0004430) | 3.51526515 |
33 | Pseudobulbar signs (HP:0002200) | 3.42809097 |
34 | Hypoalphalipoproteinemia (HP:0003233) | 3.41517057 |
35 | Hemiparesis (HP:0001269) | 3.40731056 |
36 | Xanthomatosis (HP:0000991) | 3.40417748 |
37 | Hyperglycinuria (HP:0003108) | 3.39469828 |
38 | Panhypogammaglobulinemia (HP:0003139) | 3.35665634 |
39 | Encephalitis (HP:0002383) | 3.30694921 |
40 | Polycythemia (HP:0001901) | 3.29825436 |
41 | Meningitis (HP:0001287) | 3.26481186 |
42 | IgG deficiency (HP:0004315) | 3.23657411 |
43 | Increased IgM level (HP:0003496) | 3.22193379 |
44 | Lymphopenia (HP:0001888) | 3.18958405 |
45 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.16272695 |
46 | Autoimmune hemolytic anemia (HP:0001890) | 3.14579332 |
47 | Adactyly (HP:0009776) | 3.14372762 |
48 | Keratoconjunctivitis sicca (HP:0001097) | 3.11581909 |
49 | Abnormality of the nasal mucosa (HP:0000433) | 3.10683065 |
50 | Eosinophilia (HP:0001880) | 3.08829621 |
51 | Vasculitis (HP:0002633) | 3.07978788 |
52 | Abnormality of glycine metabolism (HP:0010895) | 3.06090387 |
53 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.06090387 |
54 | Leukocytosis (HP:0001974) | 3.05983524 |
55 | Recurrent viral infections (HP:0004429) | 3.05411332 |
56 | Abnormality of eosinophils (HP:0001879) | 3.05403666 |
57 | Mediastinal lymphadenopathy (HP:0100721) | 3.05048177 |
58 | Humeroradial synostosis (HP:0003041) | 2.99644903 |
59 | Synostosis involving the elbow (HP:0003938) | 2.99644903 |
60 | Short hallux (HP:0010109) | 2.97436440 |
61 | Granulocytopenia (HP:0001913) | 2.95745131 |
62 | Increased IgE level (HP:0003212) | 2.95356005 |
63 | Mesangial abnormality (HP:0001966) | 2.91754836 |
64 | Pulmonary infiltrates (HP:0002113) | 2.90619659 |
65 | Keratoconjunctivitis (HP:0001096) | 2.89919628 |
66 | Gastrointestinal infarctions (HP:0005244) | 2.88534366 |
67 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.88371311 |
68 | Status epilepticus (HP:0002133) | 2.87356395 |
69 | Tetraparesis (HP:0002273) | 2.83587076 |
70 | Recurrent cutaneous fungal infections (HP:0011370) | 2.81887351 |
71 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.81887351 |
72 | Inflammation of the large intestine (HP:0002037) | 2.76905970 |
73 | Agammaglobulinemia (HP:0004432) | 2.75052499 |
74 | Hemoptysis (HP:0002105) | 2.73918741 |
75 | Recurrent skin infections (HP:0001581) | 2.73323530 |
76 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.73040609 |
77 | Ketoacidosis (HP:0001993) | 2.71981763 |
78 | Chest pain (HP:0100749) | 2.69913520 |
79 | Pulmonary embolism (HP:0002204) | 2.68048419 |
80 | Amyloidosis (HP:0011034) | 2.67925354 |
81 | IgM deficiency (HP:0002850) | 2.66951787 |
82 | Colitis (HP:0002583) | 2.62390120 |
83 | Sensorimotor neuropathy (HP:0007141) | 2.60982149 |
84 | Combined immunodeficiency (HP:0005387) | 2.60392229 |
85 | Gastrointestinal inflammation (HP:0004386) | 2.60214234 |
86 | Atrioventricular block (HP:0001678) | 2.58596330 |
87 | Papilledema (HP:0001085) | 2.54016100 |
88 | Hypoplastic heart (HP:0001961) | 2.53687313 |
89 | Cellulitis (HP:0100658) | 2.53475132 |
90 | Prolonged bleeding time (HP:0003010) | 2.48495272 |
91 | Hypergammaglobulinemia (HP:0010702) | 2.43220998 |
92 | Papilloma (HP:0012740) | 2.40941002 |
93 | Verrucae (HP:0200043) | 2.40941002 |
94 | Slow saccadic eye movements (HP:0000514) | 2.40475335 |
95 | Obstructive lung disease (HP:0006536) | 2.39887246 |
96 | Chronic obstructive pulmonary disease (HP:0006510) | 2.39887246 |
97 | Joint swelling (HP:0001386) | 2.36232538 |
98 | Long nose (HP:0003189) | 2.36201256 |
99 | Nasal polyposis (HP:0100582) | 2.34493111 |
100 | Microcytic anemia (HP:0001935) | 2.34251939 |
101 | Exercise-induced myalgia (HP:0003738) | 2.33028672 |
102 | Myocardial infarction (HP:0001658) | 2.32884948 |
103 | Absent hair (HP:0002298) | 2.32771891 |
104 | Abnormality of T cell physiology (HP:0011840) | 2.32757268 |
105 | Onycholysis (HP:0001806) | 2.28245559 |
106 | Chronic diarrhea (HP:0002028) | 2.27615276 |
107 | Epistaxis (HP:0000421) | 2.24387113 |
108 | Ketosis (HP:0001946) | 2.23283486 |
109 | Hyperammonemia (HP:0001987) | 2.21925449 |
110 | Autoimmune thrombocytopenia (HP:0001973) | 2.20426552 |
111 | Gingivitis (HP:0000230) | 2.17762495 |
112 | Esophageal varix (HP:0002040) | 2.16581782 |
113 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.13751602 |
114 | Deep venous thrombosis (HP:0002625) | 2.12700687 |
115 | Interstitial pulmonary disease (HP:0006530) | 2.11886020 |
116 | Muscle fiber splitting (HP:0003555) | 2.10652394 |
117 | Abnormality of the pleura (HP:0002103) | 2.10332257 |
118 | Hypolipoproteinemia (HP:0010981) | 2.09976013 |
119 | Late onset (HP:0003584) | 2.09939773 |
120 | Stroke (HP:0001297) | 2.08668628 |
121 | Supranuclear gaze palsy (HP:0000605) | 2.07737096 |
122 | Thyroiditis (HP:0100646) | 2.07217094 |
123 | Sepsis (HP:0100806) | 2.06597761 |
124 | Polygenic inheritance (HP:0010982) | 2.04483158 |
125 | Hypoplasia of the thymus (HP:0000778) | 2.04400021 |
126 | Stomach cancer (HP:0012126) | 2.03885310 |
127 | Hyperglycinemia (HP:0002154) | 2.03832245 |
128 | Hydroxyprolinuria (HP:0003080) | 2.02345222 |
129 | Abnormality of proline metabolism (HP:0010907) | 2.02345222 |
130 | Paraparesis (HP:0002385) | 2.02105819 |
131 | Gastrointestinal stroma tumor (HP:0100723) | 2.01475636 |
132 | Hematochezia (HP:0002573) | 2.00811025 |
133 | Heart block (HP:0012722) | 1.99736909 |
134 | Spontaneous hematomas (HP:0007420) | 1.99535059 |
135 | Large for gestational age (HP:0001520) | 1.99158785 |
136 | Confusion (HP:0001289) | 1.98288066 |
137 | Arterial thrombosis (HP:0004420) | 1.97660307 |
138 | Vertigo (HP:0002321) | 1.96824010 |
139 | Difficulty running (HP:0009046) | 1.94741989 |
140 | Broad metatarsal (HP:0001783) | 1.94435744 |
141 | Chronic sinusitis (HP:0011109) | 1.93729652 |
142 | Abnormality of B cell number (HP:0010975) | 1.92316985 |
143 | Mixed hearing impairment (HP:0000410) | 1.91393772 |
144 | Asymmetric septal hypertrophy (HP:0001670) | 1.90551551 |
145 | Conjunctival telangiectasia (HP:0000524) | 1.89732967 |
146 | Absent toe (HP:0010760) | 1.89295715 |
147 | Split foot (HP:0001839) | 1.89233170 |
148 | Episodic fever (HP:0001954) | 1.88295919 |
149 | Facial shape deformation (HP:0011334) | 1.87065120 |
150 | Potter facies (HP:0002009) | 1.87065120 |
151 | Bronchitis (HP:0012387) | 1.86526991 |
152 | Emphysema (HP:0002097) | 1.84177920 |
153 | Dementia (HP:0000726) | 1.84057875 |
154 | Increased CSF protein (HP:0002922) | 1.83485503 |
155 | Hypoproteinemia (HP:0003075) | 1.83430567 |
156 | B lymphocytopenia (HP:0010976) | 1.82382415 |
157 | Mitral stenosis (HP:0001718) | 1.82273716 |
158 | Multifactorial inheritance (HP:0001426) | 1.81881267 |
159 | Visceral angiomatosis (HP:0100761) | 1.81866634 |
160 | Acne (HP:0001061) | 1.81585913 |
161 | Arterial tortuosity (HP:0005116) | 1.81440478 |
162 | Urticaria (HP:0001025) | 1.80488825 |
163 | Hypoglycemic coma (HP:0001325) | 1.80324472 |
164 | Progressive neurologic deterioration (HP:0002344) | 1.78032679 |
165 | Abnormality of the dental pulp (HP:0006479) | 1.76778002 |
166 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.76306696 |
167 | Abnormal atrioventricular conduction (HP:0005150) | 1.76025358 |
168 | Rigidity (HP:0002063) | 1.74875020 |
169 | Hypoglycemic seizures (HP:0002173) | 1.74673383 |
170 | Hemangiomatosis (HP:0007461) | 1.74646657 |
171 | Chronic otitis media (HP:0000389) | 1.70999310 |
172 | Epileptic encephalopathy (HP:0200134) | 1.70482165 |
173 | Hypertriglyceridemia (HP:0002155) | 1.69083498 |
174 | Narrow nasal bridge (HP:0000446) | 1.68526410 |
175 | Ectopia lentis (HP:0001083) | 1.67319038 |
176 | Delayed CNS myelination (HP:0002188) | 1.67224747 |
177 | Postural instability (HP:0002172) | 1.65167807 |
178 | Blepharitis (HP:0000498) | 1.64506632 |
179 | Broad alveolar ridges (HP:0000187) | 1.64490880 |
180 | Dry hair (HP:0011359) | 1.63779793 |
181 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.63369240 |
182 | Hypercholesterolemia (HP:0003124) | 1.62842034 |
183 | Fibular aplasia (HP:0002990) | 1.62042479 |
184 | Abnormality of nail color (HP:0100643) | 1.61773659 |
185 | Focal motor seizures (HP:0011153) | 1.61494009 |
186 | T lymphocytopenia (HP:0005403) | 1.61240145 |
187 | Vascular tortuosity (HP:0004948) | 1.60276182 |
188 | Craniofacial hyperostosis (HP:0004493) | 1.59839875 |
189 | Bronchomalacia (HP:0002780) | 1.59389170 |
190 | Athetosis (HP:0002305) | 1.58117646 |
Rank | Gene Set | Z-score |
---|---|---|
1 | LMTK2 | 4.70504681 |
2 | EPHA4 | 4.67495862 |
3 | PHKG1 | 3.27605280 |
4 | PHKG2 | 3.27605280 |
5 | TRIB3 | 3.16254046 |
6 | SIK1 | 2.84516805 |
7 | TIE1 | 2.62264049 |
8 | NTRK2 | 2.42163943 |
9 | RIPK4 | 2.36074697 |
10 | TNIK | 2.21388453 |
11 | GRK6 | 2.09915671 |
12 | MAPK12 | 1.99863835 |
13 | MAP4K1 | 1.92948752 |
14 | CAMKK2 | 1.88347383 |
15 | PRKD3 | 1.85744288 |
16 | TAOK3 | 1.85494916 |
17 | MUSK | 1.81552180 |
18 | MAP3K13 | 1.76974438 |
19 | KDR | 1.70384475 |
20 | SYK | 1.62696303 |
21 | ERN1 | 1.60758567 |
22 | FGFR3 | 1.59825851 |
23 | FGFR4 | 1.53618680 |
24 | TGFBR2 | 1.49792032 |
25 | RIPK1 | 1.48375550 |
26 | BLK | 1.48082830 |
27 | TXK | 1.44080509 |
28 | JAK3 | 1.42178611 |
29 | PRKCH | 1.37222718 |
30 | SGK2 | 1.35931203 |
31 | JAK1 | 1.33219558 |
32 | IRAK3 | 1.32222441 |
33 | IRAK4 | 1.31697239 |
34 | SGK3 | 1.31578021 |
35 | TESK2 | 1.28967251 |
36 | EPHA3 | 1.28590709 |
37 | MAPK7 | 1.27437417 |
38 | NLK | 1.24474605 |
39 | ITK | 1.21569506 |
40 | FGFR2 | 1.21320168 |
41 | STK10 | 1.17817493 |
42 | SIK3 | 1.16264406 |
43 | MAP2K3 | 1.15436441 |
44 | MAP3K7 | 1.11053639 |
45 | TYK2 | 1.09223729 |
46 | PRKD2 | 1.03730024 |
47 | PASK | 1.03592578 |
48 | DMPK | 1.02805483 |
49 | PRKCQ | 1.01812920 |
50 | LRRK2 | 1.00838586 |
51 | SGK494 | 0.94435054 |
52 | SGK223 | 0.94435054 |
53 | MAP3K14 | 0.93008381 |
54 | MAP3K11 | 0.93004855 |
55 | TYRO3 | 0.91383147 |
56 | MOS | 0.91165237 |
57 | MAP3K10 | 0.88122924 |
58 | FES | 0.85158101 |
59 | SIK2 | 0.83519458 |
60 | BMPR2 | 0.83395709 |
61 | CSK | 0.80346858 |
62 | MAP3K3 | 0.79842648 |
63 | IKBKE | 0.79144198 |
64 | MAP3K1 | 0.77577719 |
65 | NEK9 | 0.76349625 |
66 | HCK | 0.76007044 |
67 | IRAK1 | 0.75659409 |
68 | MARK3 | 0.74395405 |
69 | PTK6 | 0.73932639 |
70 | IGF1R | 0.73678804 |
71 | PRPF4B | 0.72316892 |
72 | MAPK15 | 0.71754618 |
73 | IKBKB | 0.71635798 |
74 | EPHB1 | 0.70588662 |
75 | STK38 | 0.68871889 |
76 | JAK2 | 0.66954076 |
77 | PIM1 | 0.66820533 |
78 | PDK1 | 0.66246739 |
79 | CSF1R | 0.65628550 |
80 | TAOK2 | 0.65384265 |
81 | NTRK3 | 0.65293013 |
82 | FGR | 0.63696917 |
83 | BCKDK | 0.62935073 |
84 | PRKD1 | 0.62741849 |
85 | PINK1 | 0.62197983 |
86 | TTN | 0.61887996 |
87 | PDGFRA | 0.61277213 |
88 | PRKAA2 | 0.60955197 |
89 | INSRR | 0.60529795 |
90 | KSR2 | 0.60036206 |
91 | FGFR1 | 0.59837640 |
92 | MST4 | 0.59695863 |
93 | HIPK2 | 0.59184313 |
94 | YES1 | 0.58948480 |
95 | PKN2 | 0.58406288 |
96 | PDPK1 | 0.54889560 |
97 | PIK3CG | 0.54769300 |
98 | GRK7 | 0.54614223 |
99 | TNK2 | 0.54029458 |
100 | PAK6 | 0.53251917 |
101 | CAMK4 | 0.53127040 |
102 | CAMKK1 | 0.51990749 |
103 | PDGFRB | 0.51754785 |
104 | CDK5 | 0.51534173 |
105 | CAMK1D | 0.51015673 |
106 | LCK | 0.51012951 |
107 | CAMK1G | 0.50215320 |
108 | ADRBK1 | 0.48503873 |
109 | TBK1 | 0.48376335 |
110 | ZAP70 | 0.48144661 |
111 | TAOK1 | 0.47739622 |
112 | MAPK4 | 0.47639416 |
113 | UHMK1 | 0.47211440 |
114 | MARK2 | 0.46607394 |
115 | ROCK1 | 0.44349620 |
116 | FYN | 0.43143135 |
117 | PTK2B | 0.43002799 |
118 | MINK1 | 0.42611556 |
119 | SRC | 0.42428259 |
120 | MAPK11 | 0.42009010 |
121 | KIT | 0.41646333 |
122 | DYRK1B | 0.40732267 |
123 | CDC42BPA | 0.40666371 |
124 | ROCK2 | 0.39636100 |
125 | GRK1 | 0.39309197 |
126 | CDK4 | 0.38479281 |
127 | SGK1 | 0.37059212 |
128 | PDK3 | 0.36961216 |
129 | PDK4 | 0.36961216 |
130 | TEC | 0.36781950 |
131 | LYN | 0.36458431 |
132 | PRKACG | 0.36176282 |
133 | PRKCE | 0.35768980 |
134 | INSR | 0.35564231 |
135 | PRKCG | 0.35272616 |
136 | MELK | 0.34909069 |
137 | BTK | 0.34821676 |
138 | EPHB2 | 0.34399433 |
139 | GRK5 | 0.33757191 |
140 | PAK3 | 0.33714397 |
141 | DYRK1A | 0.33292522 |
142 | EGFR | 0.33059761 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 6.34929183 |
2 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 4.33541016 |
3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.97504455 |
4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.77858489 |
5 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.72924598 |
6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.58692128 |
7 | Allograft rejection_Homo sapiens_hsa05330 | 2.51717590 |
8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.40215095 |
9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.39507768 |
10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.05595675 |
11 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.99239165 |
12 | Measles_Homo sapiens_hsa05162 | 1.98918556 |
13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.93347754 |
14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.83576983 |
15 | Viral myocarditis_Homo sapiens_hsa05416 | 1.83513431 |
16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.81201912 |
17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.58788920 |
18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.58668068 |
19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.56993978 |
20 | Bile secretion_Homo sapiens_hsa04976 | 1.55909178 |
21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.53715210 |
22 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.50756056 |
23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.49290506 |
24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.48701615 |
25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.45627343 |
26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.36125366 |
27 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.31771750 |
28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.31483689 |
29 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.29155092 |
30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.28999876 |
31 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.27501778 |
32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27383328 |
33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.25176482 |
34 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.20758488 |
35 | Salivary secretion_Homo sapiens_hsa04970 | 1.17611178 |
36 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.16988282 |
37 | Tuberculosis_Homo sapiens_hsa05152 | 1.16422377 |
38 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.15447176 |
39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.10851694 |
40 | Hepatitis B_Homo sapiens_hsa05161 | 1.07566927 |
41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.07560975 |
42 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.06891200 |
43 | Influenza A_Homo sapiens_hsa05164 | 1.05076531 |
44 | Peroxisome_Homo sapiens_hsa04146 | 1.05031816 |
45 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.04989385 |
46 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.04040609 |
47 | Platelet activation_Homo sapiens_hsa04611 | 1.03541232 |
48 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.02247304 |
49 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.01775285 |
50 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.01459461 |
51 | GABAergic synapse_Homo sapiens_hsa04727 | 0.98768212 |
52 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.97000793 |
53 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.94445024 |
54 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.93170438 |
55 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.90844647 |
56 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.88940534 |
57 | Pertussis_Homo sapiens_hsa05133 | 0.88865488 |
58 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.88340876 |
59 | Insulin secretion_Homo sapiens_hsa04911 | 0.87376706 |
60 | Shigellosis_Homo sapiens_hsa05131 | 0.86008875 |
61 | Circadian rhythm_Homo sapiens_hsa04710 | 0.85872054 |
62 | HTLV-I infection_Homo sapiens_hsa05166 | 0.85695900 |
63 | Nicotine addiction_Homo sapiens_hsa05033 | 0.85679713 |
64 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.84889447 |
65 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.84511262 |
66 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.83619932 |
67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.80550475 |
68 | Apoptosis_Homo sapiens_hsa04210 | 0.80428766 |
69 | Colorectal cancer_Homo sapiens_hsa05210 | 0.79801612 |
70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78646235 |
71 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.78620558 |
72 | ABC transporters_Homo sapiens_hsa02010 | 0.78485920 |
73 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.77781144 |
74 | Morphine addiction_Homo sapiens_hsa05032 | 0.77432604 |
75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.77410558 |
76 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.77357517 |
77 | Asthma_Homo sapiens_hsa05310 | 0.76622250 |
78 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.75743431 |
79 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.75507192 |
80 | Malaria_Homo sapiens_hsa05144 | 0.74806726 |
81 | Prion diseases_Homo sapiens_hsa05020 | 0.74736666 |
82 | Hepatitis C_Homo sapiens_hsa05160 | 0.74665976 |
83 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.74555584 |
84 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.73925160 |
85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72582364 |
86 | Endocytosis_Homo sapiens_hsa04144 | 0.72530186 |
87 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71708625 |
88 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71707752 |
89 | Legionellosis_Homo sapiens_hsa05134 | 0.70370637 |
90 | Circadian entrainment_Homo sapiens_hsa04713 | 0.70018354 |
91 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.70004480 |
92 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.70004368 |
93 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.68939657 |
94 | Insulin resistance_Homo sapiens_hsa04931 | 0.68080513 |
95 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.67562169 |
96 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.67114350 |
97 | Cocaine addiction_Homo sapiens_hsa05030 | 0.66567525 |
98 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.66105236 |
99 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65738752 |
100 | Endometrial cancer_Homo sapiens_hsa05213 | 0.65488717 |
101 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.64597675 |
102 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.63993234 |
103 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.63049774 |
104 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62218127 |
105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.60267883 |
106 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.60123123 |
107 | Phagosome_Homo sapiens_hsa04145 | 0.59516498 |
108 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58623545 |
109 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.58493936 |
110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58445379 |
111 | Renin secretion_Homo sapiens_hsa04924 | 0.57751937 |
112 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57289553 |
113 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.57176335 |
114 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56981750 |
115 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.56228737 |
116 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.56194242 |
117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56169999 |
118 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.56000984 |
119 | Salmonella infection_Homo sapiens_hsa05132 | 0.55302357 |
120 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.54494289 |
121 | Olfactory transduction_Homo sapiens_hsa04740 | 0.52779444 |
122 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52733182 |
123 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52433176 |
124 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.52402246 |
125 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.52352248 |
126 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52150006 |
127 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52097764 |
128 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.51925844 |
129 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.51417700 |
130 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.51139630 |
131 | Long-term potentiation_Homo sapiens_hsa04720 | 0.51074181 |
132 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.50468870 |
133 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.50101103 |
134 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49907930 |
135 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.49347372 |
136 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.49022432 |
137 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.48667713 |
138 | Carbon metabolism_Homo sapiens_hsa01200 | 0.48406161 |
139 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.47956124 |
140 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.47432123 |
141 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.47337237 |
142 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.46806865 |
143 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.45860157 |
144 | Focal adhesion_Homo sapiens_hsa04510 | 0.45603315 |
145 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.45463209 |
146 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.45187170 |
147 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.44821202 |
148 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.43270024 |
149 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.42611514 |
150 | Mineral absorption_Homo sapiens_hsa04978 | 0.42125711 |
151 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.41257241 |
152 | Melanogenesis_Homo sapiens_hsa04916 | 0.40384058 |
153 | Sulfur relay system_Homo sapiens_hsa04122 | 0.40075375 |
154 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40069446 |
155 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.40037131 |
156 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.39491621 |
157 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38770036 |
158 | Glioma_Homo sapiens_hsa05214 | 0.38718483 |
159 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.37956154 |
160 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36217633 |
161 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.35785974 |
162 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.35651432 |
163 | Lysosome_Homo sapiens_hsa04142 | 0.33471851 |
164 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.33313056 |
165 | Lysine degradation_Homo sapiens_hsa00310 | 0.32214214 |
166 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.31487230 |
167 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.30540537 |
168 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.30539299 |
169 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.30277997 |
170 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.29393990 |
171 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.28844983 |